SF Easyhaler + charcoal

Salmeterol/Fluticasone Easyhaler (SF Easyhaler) is a combination dry powder inhaler developed by Orion Corporation for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It delivers a fixed-dose combination of salmeterol xinafoate, a long-acting beta-2 adrenoceptor agonist (LABA) that provides sustained bronchodilation, and fluticasone propionate, a synthetic corticosteroid with potent anti-inflammatory action. In clinical pharmacology, "SF Easyhaler + charcoal" refers to the administration of the inhaler alongside activated charcoal. This protocol is specifically used in pharmacokinetic studies to block the gastrointestinal absorption of the swallowed portion of the inhaled dose, thereby allowing researchers to isolate and assess the pulmonary deposition and absorption of the active ingredients.

Brand names

Safumix Easyhaler

Other names

Salmeterol/Fluticasone Easyhaler + charcoalSalmeterol/Fluticasone Propionate Easyhaler